Skandinaviska Enskilda Banken (SEB)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Sell
4,142
-3,991,313
-100% -$233M 0.01% 149
2025
Q4
$216M Buy
3,995,455
+275,468
+7% +$13.3M 0.86% 19
2025
Q3
$168M Buy
3,719,987
+1,393,646
+60% +$65.1M 0.67% 24
2025
Q2
$108M Buy
2,326,341
+1,013,851
+77% +$49.8M 0.47% 39
2025
Q1
$80M Sell
1,312,490
-44,816
-3% -$2.61M 0.39% 47
2024
Q4
$76.1M Buy
1,357,306
+856,640
+171% +$47.9M 0.34% 51
2024
Q3
$25.9M Sell
500,666
-864,618
-63% -$40.6M 0.12% 146
2024
Q2
$56.7M Buy
1,365,284
+935,273
+217% +$41.8M 0.27% 68
2024
Q1
$23.3M Sell
430,011
-5,206
-1% -$265K 0.11% 167
2023
Q4
$22.3M Buy
435,217
+1,423
+0.3% +$74.7K 0.13% 152
2023
Q3
$25.2M Sell
433,794
-197,018
-31% -$12.1M 0.17% 124
2023
Q2
$40.3M Sell
630,812
-321,089
-34% -$21.5M 0.26% 78
2023
Q1
$66M Buy
951,901
+9,321
+1% +$657K 0.46% 46
2022
Q4
$67.8M Sell
942,580
-33,273
-3% -$2.51M 0.51% 38
2022
Q3
$69.4M Sell
975,853
-199,157
-17% -$14.4M 0.54% 43
2022
Q2
$90.5M Sell
1,175,010
-362,178
-24% -$27.6M 0.67% 28
2022
Q1
$112M Sell
1,537,188
-234,330
-13% -$15.7M 0.66% 25
2021
Q4
$111M Sell
1,771,518
-98,711
-5% -$5.79M 0.57% 36
2021
Q3
$111M Sell
1,870,229
-295,761
-14% -$19.5M 0.61% 30
2021
Q2
$145M Buy
2,165,990
+315,101
+17% +$20.5M 0.89% 16
2021
Q1
$117M Buy
1,850,889
+832,407
+82% +$51.8M 0.77% 22
2020
Q4
$63.2M Sell
1,018,482
-805,235
-44% -$49.5M 0.43% 51
2020
Q3
$110M Sell
1,823,717
-925,004
-34% -$55.7M 0.8% 20
2020
Q2
$162M Sell
2,748,721
-249,140
-8% -$14.9M 1.31% 10
2020
Q1
$167M Sell
2,997,861
-740,037
-20% -$45.2M 1.69% 7
2019
Q4
$240M Buy
3,737,898
+463,099
+14% +$26.5M 1.89% 4
2019
Q3
$166M Buy
3,274,799
+425,799
+15% +$20M 1.4% 12
2019
Q2
$129M Buy
2,849,000
+448,994
+19% +$20.9M 1.11% 20
2019
Q1
$115M Buy
2,400,006
+1,521,399
+173% +$75.8M 1.05% 22
2018
Q4
$45.7M Buy
878,607
+382,196
+77% +$20.5M 0.41% 54
2018
Q3
$30.8M Buy
496,411
+212,091
+75% +$12.6M 0.23% 93
2018
Q2
$15.7M Buy
284,320
+91,286
+47% +$4.93M 0.13% 128
2018
Q1
$12.2M Sell
193,034
-1,419,631
-88% -$91.3M 0.12% 129
2017
Q4
$98.8M Buy
1,612,665
+129,984
+9% +$8.13M 0.85% 31
2017
Q3
$94.5M Sell
1,482,681
-93,200
-6% -$5.44M 0.86% 27
2017
Q2
$87.8M Buy
1,575,881
+1,290,070
+451% +$70.2M 0.84% 26
2017
Q1
$15.5M Buy
285,811
+17
+0% +$932 0.16% 120
2016
Q4
$16.7M Sell
285,794
-3,086
-1% -$169K 0.2% 87
2016
Q3
$15.6M Buy
288,880
+5,600
+2% +$360K 0.17% 103
2016
Q2
$20.8M Buy
283,280
+13,650
+5% +$965K 0.23% 82
2016
Q1
$17.2M Sell
269,630
-4,670
-2% -$295K 0.19% 91
2015
Q4
$18.9M Buy
+274,300
New +$18.1M 0.24% 79

Other funds holding BMY

Skandinaviska Enskilda Banken (SEB)'s BMY Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q1 2026, selling an estimated $233M and leaving 4,142 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #149.

Skandinaviska Enskilda Banken (SEB) first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $240M in Q4 2019. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) held 4,142 shares of Bristol-Myers Squibb worth $251K as of Q1 2026.
  • Skandinaviska Enskilda Banken (SEB) sold 3,991,313 Bristol-Myers Squibb shares in Q1 2026, an estimated $233M.
  • Bristol-Myers Squibb made up 0.01% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q1 2026, its #149 holding.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
  • Skandinaviska Enskilda Banken (SEB)'s Bristol-Myers Squibb position peaked at $240M in Q4 2019.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.